Previous Article | Next Article ![]()
Journal of Virology, February 2000, p. 1241-1251, Vol. 74, No. 3
Department of Internal Medicine and
Therapeutics,1 Department of
Microbiology,2 Department of General
Medicine,3 and Department of
Molecular Therapeutics,4 Osaka University
Graduate School of Medicine, Suita, Osaka 565-0871, Japan
Received 28 May 1999/Accepted 3 November 1999
Hepatitis B virus (HBV) enhancer II (EnII) is a hepatotropic
cis element which is responsible for the
hepatocyte-specific gene expression of HBV. Multiple transcription
factors have been demonstrated to interact with this region. In this
study, the region from HBV nucleotides (nt) 1640 to 1663 in EnII was
demonstrated to be essential for enhancer activity and to be another
target sequence of putative transcription factors. To elucidate the
factors which bind to this region, we used a yeast one-hybrid screening system and cloned three transcription factors, HLF, FTF, and E4BP4, from a human adult liver cDNA library. All of these factors had binding
affinity to the sequence from nt 1640 to 1663. Investigation of the
effects of these factors on transcriptional regulation revealed that
HLF and FTF had stimulatory activity on nt 1640 to 1663, whereas E4BP4
had a suppressing effect. FTF coordinately activated both 3.5-kb RNA
and 2.4/2.1-kb RNA transcription in a transient transfection assay with
an HBV expression vector. HLF, however, activated only 3.5-kb RNA
transcription, and in primer extension analysis, HLF strongly
stimulated the synthesis of pregenome RNA compared to precore RNA.
Thus, FTF stimulated the activity of the second enhancer, while HLF
stimulated the activity of the core upstream regulatory sequence, which
affects only the core promoter, and had a dominant effect on the
pregenome RNA synthesis.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Identification of Multiple Transcription Factors,
HLF, FTF, and E4BP4, Controlling Hepatitis B Virus Enhancer
II
*
Corresponding author. Mailing address: Department of
Molecular Therapeutics, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. Phone: 81-6-6879-3441. Fax: 81-6-6879-3449. E-mail:
hayashi{at}moltx.med.osaka-u.ac.jp.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|